Atlas Trials

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Clinical trial NCT01649661 · COMPLETED

Trial details

NCT number
NCT01649661
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Cancer Free Women
Start date
2012-07-01
Primary completion
2023-01-25
Enrollment
437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.